US HB4263 | 2023-2024 | 118th Congress
Status
Spectrum: Moderate Partisan Bill (Democrat 41-12)
Status: Introduced on June 21 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 21 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug intended for human use to identify each ingredient in such drug that is, or is derived directly or indirectly from, a major food allergen or a gluten-containing grain, and for other purposes.
Title
ADINA Act Allergen Disclosure In Non-food Articles Act
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-23 | House | Referred to the Subcommittee on Health. |
| 2023-06-21 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-21 | House | Introduced in House |
Same As/Similar To
SB2079 (Same As) 2023-06-21 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/4263/all-info |
| Text | https://www.congress.gov/118/bills/hr4263/BILLS-118hr4263ih.pdf |
